Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Omicia's Opal Clinical; Genetworx' Personal Health Panel


Omicia has launched Opal Clinical, a software solution for diagnostic testing. The software includes algorithms for interpreting next-generation sequencing data, including gene panels, exomes, and whole-genomes. The software is both HIPAA and CLIA compliant and can be integrated with LIMS and electronic health records.

Genetworx has launched its Personal Health Panel, a next-generation sequencing-based test to detect pathogens that cause infectious diseases such as sexually transmitted diseases and viruses that infect the gastrointestinal tract. It will also detect pathogens that are resistant to common drugs.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.